Chronic Cannabis Smokers Had More Belly Fat and Fat Cell Insulin Resistance but Normal Blood Sugar | Research

The takeaway

Chronic cannabis smokers had higher visceral abdominal fat, lower HDL cholesterol, and insulin resistance in fat cells, but showed no differences in liver fat, blood sugar control, or pancreatic function compared to matched controls.

Read this if you are a regular cannabis user concerned about metabolic health.

18% vs. 12% visceral fat, but preserved glucose tolerance

What the researchers found

Thirty chronic cannabis smokers (median 9.5 years use, 6 joints/day) were compared to 30 matched controls. Cannabis smokers had higher carbohydrate intake and more visceral abdominal fat (18% vs. 12%, p=0.004) but no difference in total body fat or liver fat content.

HDL cholesterol was lower in smokers (49 vs. 55 mg/dL, p=0.02). Fat cells showed insulin resistance, with higher adipocyte insulin resistance index and less free fatty acid suppression during glucose testing. However, whole-body insulin sensitivity, pancreatic beta-cell function, incretin hormones, and glucose tolerance were all normal. This suggests cannabis selectively affects fat tissue metabolism without disrupting overall glucose control.

Why it matters

This study helps resolve the paradox of cannabis and metabolism. While epidemiological studies associate cannabis use with lower obesity and diabetes rates, this controlled comparison found some metabolic harms (visceral fat, HDL, fat cell insulin resistance). The preserved glucose tolerance despite these changes suggests a complex metabolic picture.

The numbers in context

30 smokers vs. 30 controls, matched. Median use: 9.5 years, 6 joints/day. Visceral fat: 18% vs. 12% (p=0.004). HDL: 49 vs. 55 mg/dL (p=0.02). Fat cell insulin resistance: increased (p<0.05). Glucose, liver fat, beta-cell function: no difference.

How the study worked

Cross-sectional, case-control study. 30 cannabis smokers matched to 30 controls by age, sex, ethnicity, and BMI. MRI quantified abdominal fat depots. Proton magnetic resonance spectroscopy measured liver fat. Oral glucose tolerance tests assessed insulin sensitivity and beta-cell function.

What this study cannot tell us

Cross-sectional design cannot establish causation. Heavy cannabis smokers may differ from controls in unmeasured lifestyle factors (diet quality, physical activity patterns). Self-reported cannabis use. Relatively small sample. The higher carbohydrate intake in smokers may partially explain metabolic differences.

How to read the evidence

Well-matched case-control study with advanced metabolic measurements; moderate evidence for selective metabolic effects.

When this study was published

Published in 2013. Cannabis and metabolic health has become an increasingly studied topic.

The bigger picture

The selective metabolic effects of cannabis are consistent with the widespread distribution of cannabinoid receptors in metabolic tissues. The endocannabinoid system plays different roles in fat, liver, pancreas, and muscle, which could explain why cannabis affects some metabolic parameters but not others.

Questions still open

Does the increased visceral fat translate to increased cardiovascular risk over time? Would cessation reverse the metabolic changes? Does the method of cannabis consumption matter for metabolic effects? Why is glucose tolerance preserved despite fat cell insulin resistance?

Common questions

Does cannabis cause belly fat?

This study found chronic cannabis smokers had significantly more visceral (belly) fat than matched controls (18% vs. 12%), despite no difference in total body fat. However, the study cannot determine causation. Cannabis users also consumed more carbohydrates, which could contribute. The relationship between cannabis and body fat distribution is complex and not fully understood.

Is cannabis bad for cholesterol?

Cannabis smokers in this study had lower HDL ("good") cholesterol: 49 vs. 55 mg/dL. Lower HDL is associated with increased cardiovascular risk. Other cholesterol measures (LDL, total cholesterol, triglycerides) were not different. Whether this HDL difference translates to actual cardiovascular outcomes requires longer-term studies.

Read the original research

Metabolic effects of chronic cannabis smoking.

Diabetes care, 36(8), 2415-22

View on PubMed ↗Publisher’s paper ↗

Citation

Muniyappa, Ranganath; Sable, Sara; Ouwerkerk, Ronald; Mari, Andrea; Gharib, Ahmed M; Walter, Mary; Courville, Amber; Hall, Gail; Chen, Kong Y; Volkow, Nora D; Kunos, George; Huestis, Marilyn A; Skarulis, Monica C. (2013). Metabolic effects of chronic cannabis smoking.. Diabetes care, 36(8), 2415-22. https://doi.org/10.2337/dc12-2303